Premenstrual Complaints. I. Prevalence of Premenstrual Symptoms in a Swedish Urban Population

Andersch, Björn; Wendestam, Christer; Hahn, Lennart; Öhman, Rolf

doi:10.3109/01674828609016741

Cited by 91 publications

(44 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Enquanto um estudo sueco detectou ocorrência de irritabilidade pré-menstrual moderada em 31% e grave em 3% das mulheres 7 , quase 40% de nossas entrevistadas indicaram esse sintoma intensamente, o que nos remete a diferenças culturais que poderiam influir no desenvolvimento do problema. Na seqüência, os sintomas mais relacionados foram cansaço, em 70,9% dos casos, e depressão em 61,8%.…”

Section: Discussionunclassified

Prevalência dos Sintomas da Síndrome Pré-Menstrual

Nogueira¹,

Silva²

2000

Rev. Bras. Ginecol. Obstet.

View full text Add to dashboard Cite

de que os sintomas, tanto psíquicos quanto somáticos, continuaram a ocorrer na data projetada mesmo quando a menstruação foi induzida logo após a ovulação, por mifepristona ou luteólise por HCG, sugere que o evento desencadeador aconteça no primeiro período do ciclo.Conforme a manifestação principal foram definidos quatro grupos: A, se predomina ansiedade, irritabilidade ou tensão nervosa; H, se predominam edema, dores abdominais, mastalgia e ganho de peso; C, com cefaléia, podendo ser acompanhada por aumento de apetite, desejo de doces, fadiga, palpitação e tremores, e finalmente o D, se o quadro depressivo é preponderante, com insônia, choro fácil, esquecimento e confusão. Cada um estaria relacionado a fatores desencadeantes diferentes 6 . Propomos analisar os sintomas e os dife-

show abstract

Section: Discussionunclassified

Prevalência dos Sintomas da Síndrome Pré-Menstrual

Nogueira¹,

Silva²

2000

Rev. Bras. Ginecol. Obstet.

View full text Add to dashboard Cite

show abstract

“…80±90%), the prevalence of severe PERI-MS is generally quite low (i.e. 4±9% (1); 0.6±3.2% (2)). Similar prevalence estimates were also reported in studies of less representative samples (3,4).…”

Section: Introductionmentioning

confidence: 99%

The epidemiology of perimenstrual psychological symptoms

Angst¹,

Sellaro²,

Stolar³

et al. 2001

Acta Psychiatr Scand

255

157

View full text Add to dashboard Cite

Objective: The purpose of this paper is to examine the prevalence, clinical signi®cance and comorbidity of perimenstrual symptoms/ syndrome (PERI-MS) in a community sample of women. Method: Premenstrual and menstrual physical and psychological symptoms were assessed in a prospective longitudinal study of a representative community cohort of women (N=299) who were interviewed ®ve times between the ages of 21 and 35 years. Results: When classi®ed according to the severity of distress, the prevalence rates were 8.1% for severe and 13.6% for moderate PERI-MS, respectively. Clinical indicators of severity were all greater among PERI-MS women with than without depressed mood. Conclusion:The results of this study suggest that irritability, nervousness and tension irrespective of the presence of concomitant depressed mood are core elements of the perimenstrual syndrome.

show abstract

“…Most women of fertile age experience mild premen-0893-133X/93/$6.00 strual complaints (Reid 1985;Andersch et al 1986;Chi hal 1987); needless to say, a majority of these women are capable of mastering their symptoms without medi cation. However, several independent studies indicate that as much as 10% of all menstruating women have premenstrual complaints of such severity that they would like to medicate to reduce them (Reid 1985;An dersch et al 1986;Chihal 1987).…”

mentioning

confidence: 99%

Clomipramine Administered during the Luteal Phase Reduces the Symptoms of Premenstrual Syndrome: A Placebo-Controlled Trial

Sundblad

Hedberg

Eriksson

1993

Neuropsychopharmacol

146

View full text Add to dashboard Cite

II. previous controlled trial we have shown that pmntTIstrual irritability and depressed mood t,mnenstrual syndrome) can be effectively reduced by ... doses of the potent (but nonselective) serotonin nptake inhibitor clomipramine taken each day of the f/tIIS trual cycle. The present study was undertaken toGIIfI ine to what extent intermittent administration of dDmipramine, during the luteal phase only, is also Iftdive against premenstrual complaints. Twenty-nine ..dtpressed women displaying severe premenstrual iriMbility and/or depressed mood and fulfilling the DSM·/ll ·R criteria of late luteal phase dysphoric disorder IrIr treated daily from the day of ovulation until the .n of the menstruation either with clomipramine (25 � 7S mg) (n = 15) or with placebo (n = 14) for three III/StCU tive menstrual cycles; another nine subjects (seven • cIomipramine, two on placebo) dropped out during lIJIment. In both treatment groups self-rated rmnmstrual irritability and depressed mood (as III WORDS: Premenstrual syndrome; Late luteal phase .".oTic disorder; Clomipramine; Antidepressant; �onin re uptake inhibitor fIum the Department of Pharmacology (CS, EE), and the Depart

show abstract

Premenstrual Complaints. I. Prevalence of Premenstrual Symptoms in a Swedish Urban Population

Cited by 91 publications

References 17 publications

Prevalência dos Sintomas da Síndrome Pré-Menstrual

Prevalência dos Sintomas da Síndrome Pré-Menstrual

The epidemiology of perimenstrual psychological symptoms

Clomipramine Administered during the Luteal Phase Reduces the Symptoms of Premenstrual Syndrome: A Placebo-Controlled Trial

Contact Info

Product

Resources

About